NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

Medicare covers transcranial magnetic stimulation (TMS) but only as treatment for severe major depressive disorder (MDD). There are additional eligibility requirements you must meet and out-of-pocket ...

Transcranial magnetic stimulation, or "TMS," is an FDA-approved psychiatric treatment for major depressive disorder and obsessive-compulsive disorder (OCD), with intriguing clinical trials suggesting ...

Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate specific areas of the brain. It’s shown promise in treating obsessive-compulsive disorder (OCD), including cases that may not ...